Symbols / ISPC
ISPC Chart
About
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers worldwide. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. Its marketplace offers human biospecimens, including Biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; Solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and Hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. The company serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Diagnostics & Research | Market Cap | 2.48M |
| Enterprise Value | 9.83K | Income | -11.53M | Sales | 3.35M |
| Book/sh | 0.31 | Cash/sh | 0.28 | Dividend Yield | — |
| Payout | 0.00% | Employees | 24 | IPO | — |
| P/E | — | Forward P/E | -0.32 | PEG | — |
| P/S | 0.74 | P/B | 0.81 | P/C | — |
| EV/EBITDA | -0.00 | EV/Sales | 0.00 | Quick Ratio | 0.51 |
| Current Ratio | 0.63 | Debt/Eq | 9.16 | LT Debt/Eq | — |
| EPS (ttm) | -7.82 | EPS next Y | -0.79 | EPS Growth | — |
| Revenue Growth | -96.00% | Earnings | 2024-08-06 09:00 | ROA | -74.84% |
| ROE | -296.20% | ROIC | — | Gross Margin | 21.55% |
| Oper. Margin | -26.55% | Profit Margin | 0.00% | Shs Outstand | 9.77M |
| Shs Float | 9.73M | Short Float | 3.22% | Short Ratio | 0.12 |
| Short Interest | — | 52W High | 3.18 | 52W Low | 0.24 |
| Beta | 1.84 | Avg Volume | 1.84M | Volume | 112.67K |
| Target Price | — | Recom | None | Prev Close | $0.26 |
| Price | $0.25 | Change | -1.28% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.26
Latest analyst target
3. DCF / Fair value
$-8.33
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.26
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2022-09-23 | main | EF Hutton | — → Buy | $4 |
| 2022-01-04 | init | Craig-Hallum | — → Buy | $20 |
| 2021-11-22 | main | EF Hutton | — → Buy | $12 |
- AI-assisted matching: iSpecimen activates new SalesStack marketplace - Stock Titan Fri, 06 Feb 2026 08
- iSpecimen (NASDAQ: ISPC): The $1.35 Biotech Quietly Engineering a $200M Financial Backbone - Yahoo Finance Fri, 08 Aug 2025 07
- Retail Trends: Can ISPC stock outperform in a bear market - July 2025 Outlook & Advanced Swing Trade Entry Alerts - baoquankhu1.vn ue, 24 Feb 2026 22
- iSpecimen Advances Digital Marketplace with SalesStack Milestone - The Globe and Mail Sat, 07 Feb 2026 08
- Is iSpecimen Stock Built to Withstand More Downside? - Trefis ue, 16 Dec 2025 08
- iSpecimen Faces Ongoing Annual Meeting Quorum Challenges - TipRanks Wed, 18 Feb 2026 22
- iSpecimen Inc (ISPC) Stock Surged 42% After-Hours: Here's The News Behind The Move - Benzinga Wed, 31 Dec 2025 08
- iSpecimen shareholders approve reverse stock split and share increase at special meeting - Investing.com Mon, 03 Nov 2025 08
- iSpecimen (ISPC) stock drops in premarket after $5.5 million convertible preferred financing - TechStock² Wed, 31 Dec 2025 08
- iSpecimen Inc. Announces $5.5 Million Securities Purchase Agreement with Accredited Investors - Quiver Quantitative ue, 30 Dec 2025 08
- ISPC Stock Shows Mixed Signals Amid Financial Uncertainty - StocksToTrade hu, 21 Aug 2025 07
- Online biospecimen marketplace raises $5.5M for marketing - Stock Titan ue, 30 Dec 2025 08
- iSpecimen Defines $200M Strategy to Power Long-Term Growth (NASDAQ: ISPC) - Yahoo Finance Fri, 08 Aug 2025 07
- iSpecimen stock falls after $5.5 million preferred stock offering - Investing.com ue, 30 Dec 2025 08
- iSpecimen's $6M Valuation Doesn't Reflect the Business-Let Alone the $200M Treasury (NASDAQ: ISPC) - ACCESS Newswire Wed, 20 Aug 2025 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -9.98M | -8.75M | -8.80M | -4.95M |
| TotalUnusualItems | 0.00 | -900.75K | ||
| TotalUnusualItemsExcludingGoodwill | 0.00 | -900.75K | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -12.50M | -11.10M | -10.25M | -8.96M |
| ReconciledDepreciation | 2.29M | 2.12M | 1.21M | 1.00M |
| ReconciledCostOfRevenue | 5.30M | 4.82M | 4.76M | 5.25M |
| EBITDA | -9.98M | -8.75M | -8.80M | -5.86M |
| EBIT | -12.28M | -10.87M | -10.01M | -6.86M |
| NetInterestIncome | -175.94K | 108.97K | -69.62K | -2.09M |
| InterestExpense | 220.07K | 230.78K | 238.96K | 2.10M |
| InterestIncome | 44.13K | 339.75K | 169.34K | 11.40K |
| NormalizedIncome | -12.50M | -11.10M | -10.25M | -8.06M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -12.50M | -11.10M | -10.25M | -8.96M |
| TotalExpenses | 22.02M | 21.10M | 20.59M | 17.06M |
| TotalOperatingIncomeAsReported | -12.73M | -11.17M | -10.19M | -5.93M |
| DilutedAverageShares | 710.85K | 452.07K | 442.21K | 214.37K |
| BasicAverageShares | 710.85K | 452.07K | 442.21K | 214.37K |
| DilutedEPS | -17.58 | -24.55 | -23.20 | -41.80 |
| BasicEPS | -17.58 | -24.55 | -23.20 | -41.80 |
| DilutedNIAvailtoComStockholders | -12.50M | -11.10M | -10.25M | -8.96M |
| NetIncomeCommonStockholders | -12.50M | -11.10M | -10.25M | -8.96M |
| NetIncome | -12.50M | -11.10M | -10.25M | -8.96M |
| NetIncomeIncludingNoncontrollingInterests | -12.50M | -11.10M | -10.25M | -8.96M |
| NetIncomeContinuousOperations | -12.50M | -11.10M | -10.25M | -8.96M |
| PretaxIncome | -12.50M | -11.10M | -10.25M | -8.96M |
| OtherIncomeExpense | 406.18K | -39.10K | 9.78K | -945.28K |
| OtherNonOperatingIncomeExpenses | 406.18K | -39.10K | 9.78K | -44.53K |
| SpecialIncomeCharges | 0.00 | -2.21M | ||
| OtherSpecialCharges | 2.21M | |||
| GainOnSaleOfSecurity | 1.31M | |||
| NetNonOperatingInterestIncomeExpense | -175.94K | 108.97K | -69.62K | -2.09M |
| InterestExpenseNonOperating | 220.07K | 230.78K | 238.96K | 2.10M |
| InterestIncomeNonOperating | 44.13K | 339.75K | 169.34K | 11.40K |
| OperatingIncome | -12.73M | -11.17M | -10.19M | -5.93M |
| OperatingExpense | 16.72M | 16.28M | 15.83M | 11.81M |
| OtherOperatingExpenses | 537.89K | 1.03M | 801.12K | 573.91K |
| ResearchAndDevelopment | 3.53M | 3.57M | 2.66M | 1.84M |
| SellingGeneralAndAdministration | 12.65M | 11.68M | 12.37M | 9.40M |
| SellingAndMarketingExpense | 4.95M | 3.96M | 3.45M | 2.42M |
| GeneralAndAdministrativeExpense | 7.70M | 7.72M | 8.93M | 6.98M |
| OtherGandA | 7.70M | 7.72M | 8.93M | 6.98M |
| GrossProfit | 3.99M | 5.11M | 5.65M | 5.89M |
| CostOfRevenue | 5.30M | 4.82M | 4.76M | 5.25M |
| TotalRevenue | 9.29M | 9.93M | 10.40M | 11.14M |
| OperatingRevenue | 9.29M | 9.93M | 10.40M | 11.14M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 1.55K | 1.55K | 1.55K | 1.55K |
| OrdinarySharesNumber | 1.70M | 454.17K | 446.29K | 436.67K |
| ShareIssued | 1.70M | 455.72K | 447.84K | 438.22K |
| TotalDebt | 312.17K | 196.24K | 185.85K | 3.42M |
| TangibleBookValue | -2.02M | 2.51M | 15.81M | 27.08M |
| InvestedCapital | 3.31M | 9.74M | 20.31M | 33.21M |
| WorkingCapital | -2.18M | 2.19M | 15.39M | 30.44M |
| NetTangibleAssets | -2.02M | 2.51M | 15.81M | 27.08M |
| CapitalLeaseObligations | 312.17K | 196.24K | 185.85K | 0.00 |
| CommonStockEquity | 3.31M | 9.74M | 20.31M | 29.79M |
| TotalCapitalization | 3.31M | 9.74M | 20.31M | 33.21M |
| TotalEquityGrossMinorityInterest | 3.31M | 9.74M | 20.31M | 29.79M |
| StockholdersEquity | 3.31M | 9.74M | 20.31M | 29.79M |
| GainsLossesNotAffectingRetainedEarnings | 0.00 | 840.00 | 0.00 | |
| OtherEquityAdjustments | 840.00 | |||
| TreasuryStock | 172.00 | 172.00 | 172.00 | 172.00 |
| RetainedEarnings | -71.86M | -59.36M | -48.27M | -38.02M |
| AdditionalPaidInCapital | 75.17M | 69.11M | 68.57M | 67.81M |
| CapitalStock | 170.00 | 45.00 | 892.00 | 873.00 |
| CommonStock | 170.00 | 45.00 | 892.00 | 873.00 |
| TotalLiabilitiesNetMinorityInterest | 6.04M | 6.08M | 4.31M | 5.93M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 268.80K | 29.13K | 27.40K | 3.42M |
| LongTermDebtAndCapitalLeaseObligation | 268.80K | 29.13K | 27.40K | 3.42M |
| LongTermCapitalLeaseObligation | 268.80K | 29.13K | 27.40K | 0.00 |
| LongTermDebt | 3.42M | |||
| CurrentLiabilities | 5.77M | 6.05M | 4.28M | 2.51M |
| CurrentDeferredLiabilities | 360.71K | 415.77K | 132.34K | 654.75K |
| CurrentDeferredRevenue | 360.71K | 415.77K | 132.34K | 654.75K |
| CurrentDebtAndCapitalLeaseObligation | 43.37K | 167.11K | 158.45K | |
| CurrentCapitalLeaseObligation | 43.37K | 167.11K | 158.45K | 0.00 |
| PayablesAndAccruedExpenses | 5.37M | 5.47M | 3.99M | 1.85M |
| CurrentAccruedExpenses | 1.17M | 1.54M | 1.53M | 1.02M |
| InterestPayable | 0.00 | 8.17K | ||
| Payables | 4.20M | 3.93M | 2.46M | 832.68K |
| AccountsPayable | 4.20M | 3.93M | 2.46M | 832.68K |
| TotalAssets | 9.35M | 15.82M | 24.62M | 35.72M |
| TotalNonCurrentAssets | 5.76M | 7.58M | 4.94M | 2.77M |
| NonCurrentPrepaidAssets | 12.10K | 27.60K | 27.60K | 27.60K |
| GoodwillAndOtherIntangibleAssets | 5.33M | 7.23M | 4.50M | 2.71M |
| OtherIntangibleAssets | 5.33M | 7.23M | 4.50M | 2.71M |
| NetPPE | 421.54K | 321.64K | 410.54K | 32.78K |
| AccumulatedDepreciation | -342.06K | -444.73K | -327.19K | -304.75K |
| GrossPPE | 763.61K | 766.38K | 737.73K | 337.54K |
| Leases | 12.65K | 68.47K | 60.44K | 24.93K |
| OtherProperties | 304.67K | 320.83K | 320.83K | 140.83K |
| MachineryFurnitureEquipment | 118.31K | 183.22K | 171.77K | 171.77K |
| BuildingsAndImprovements | 327.98K | 193.86K | 184.69K | |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 3.59M | 8.24M | 19.68M | 32.95M |
| OtherCurrentAssets | 264.89K | 292.08K | 300.43K | 327.04K |
| PrepaidAssets | 327.04K | |||
| Receivables | 1.44M | 2.94M | 4.07M | 4.88M |
| OtherReceivables | 2.21M | 2.33M | 1.74M | |
| TaxesReceivable | 0.00 | 140.87K | 140.87K | |
| AccountsReceivable | 1.44M | 728.39K | 1.60M | 3.00M |
| AllowanceForDoubtfulAccountsReceivable | -620.43K | -520.90K | -231.00K | -269.17K |
| GrossAccountsReceivable | 2.07M | 1.25M | 1.83M | 3.27M |
| CashCashEquivalentsAndShortTermInvestments | 1.88M | 5.01M | 15.31M | 27.74M |
| OtherShortTermInvestments | 0.00 | 2.66M | 0.00 | |
| CashAndCashEquivalents | 1.88M | 2.34M | 15.31M | 27.74M |
| CashFinancial | 15.31M | 27.74M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -8.97M | -10.55M | -9.01M | -11.71M |
| RepaymentOfDebt | 0.00 | -3.50M | -3.00M | |
| IssuanceOfDebt | 0.00 | 4.00M | ||
| IssuanceOfCapitalStock | 1.89M | 0.00 | 0.00 | 41.50M |
| CapitalExpenditure | -709.83K | -4.74M | -3.19M | -1.04M |
| InterestPaidSupplementalData | 33.75K | 16.00K | 161.58K | 2.82M |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | ||
| EndCashPosition | 1.88M | 2.34M | 15.31M | 27.74M |
| BeginningCashPosition | 2.34M | 15.31M | 27.74M | 695.91K |
| ChangesInCash | -465.26K | -12.97M | -12.43M | 27.04M |
| FinancingCashFlow | 5.82M | 70.89K | -3.42M | 38.75M |
| CashFlowFromContinuingFinancingActivities | 5.82M | 70.89K | -3.42M | 38.75M |
| NetOtherFinancingCharges | -621.48K | -3.81M | ||
| ProceedsFromStockOptionExercised | 4.55M | 70.89K | 78.64K | 59.64K |
| NetCommonStockIssuance | 1.89M | 0.00 | 0.00 | 41.50M |
| CommonStockIssuance | 1.89M | 0.00 | 0.00 | 41.50M |
| NetIssuancePaymentsOfDebt | 0.00 | -3.50M | 1.00M | |
| NetLongTermDebtIssuance | 0.00 | -3.50M | 1.00M | |
| LongTermDebtPayments | 0.00 | -3.50M | -3.00M | |
| LongTermDebtIssuance | 0.00 | 4.00M | ||
| InvestingCashFlow | 1.98M | -7.23M | -3.19M | -1.04M |
| CashFlowFromContinuingInvestingActivities | 1.98M | -7.23M | -3.19M | -1.04M |
| NetInvestmentPurchaseAndSale | 2.69M | -2.48M | 0.00 | |
| SaleOfInvestment | 3.15M | 10.56M | 0.00 | |
| PurchaseOfInvestment | -460.93K | -13.04M | 0.00 | |
| NetIntangiblesPurchaseAndSale | -1.04M | |||
| PurchaseOfIntangibles | -1.04M | |||
| NetPPEPurchaseAndSale | -56.55K | -19.48K | -215.50K | -2.55K |
| PurchaseOfPPE | -56.55K | -19.48K | -215.50K | -2.55K |
| CapitalExpenditureReported | -653.29K | -4.73M | -2.98M | -1.04M |
| OperatingCashFlow | -8.26M | -5.81M | -5.82M | -10.67M |
| CashFlowFromContinuingOperatingActivities | -8.26M | -5.81M | -5.82M | -10.67M |
| ChangeInWorkingCapital | -502.67K | 2.59M | 2.35M | -5.28M |
| ChangeInOtherWorkingCapital | -55.06K | 283.44K | -522.41K | -218.51K |
| ChangeInOtherCurrentLiabilities | -120.20K | -155.96K | -147.28K | 0.00 |
| ChangeInOtherCurrentAssets | 127.01K | 157.19K | 148.43K | 0.00 |
| ChangeInPayablesAndAccruedExpense | -99.70K | 1.48M | 2.14M | -2.47M |
| ChangeInAccruedExpense | -371.82K | 9.37K | 513.27K | -1.51M |
| ChangeInInterestPayable | 0.00 | -8.17K | -1.71M | |
| ChangeInPayable | 272.12K | 1.47M | 1.63M | -959.75K |
| ChangeInAccountPayable | 272.12K | 1.47M | 1.63M | -959.75K |
| ChangeInPrepaidAssets | 42.69K | 8.36K | 26.60K | 90.89K |
| ChangeInReceivables | -397.40K | 820.61K | 709.18K | -2.68M |
| ChangesInAccountReceivables | -903.33K | 564.49K | 1.30M | -1.64M |
| OtherNonCashItems | -28.98K | -177.29K | 83.63K | 887.79K |
| StockBasedCompensation | 249.68K | 459.67K | 678.61K | 622.06K |
| AssetImpairmentCharge | 2.22M | 305.04K | 106.58K | 161.07K |
| DepreciationAmortizationDepletion | 2.29M | 2.12M | 1.21M | 1.00M |
| DepreciationAndAmortization | 2.29M | 2.12M | 1.21M | 1.00M |
| AmortizationCashFlow | 2.23M | 2.00M | 1.18M | 958.64K |
| AmortizationOfIntangibles | 2.23M | 2.00M | 1.18M | 958.64K |
| Depreciation | 65.71K | 117.54K | 22.43K | 45.36K |
| OperatingGainsLosses | 738.00 | 900.75K | ||
| GainLossOnInvestmentSecurities | 680.00 | -1.31M | ||
| GainLossOnSaleOfPPE | 58.00 | 0.00 | ||
| NetIncomeFromContinuingOperations | -12.50M | -11.10M | -10.25M | -8.96M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ISPC
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|